Net profit of GPT Healthcare rose 9.78% to Rs 14.82 crore in the quarter ended September 2024 as against Rs 13.50 crore during the previous quarter ended September 2023. Sales declined 2.15% to Rs 105.66 crore in the quarter ended September 2024 as against Rs 107.98 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales105.66107.98 -2 OPM %22.1722.77 - PBDT25.4923.87 7 PBT20.6919.48 6 NP14.8213.50 10 Powered by Capital Market - Live News

GPT Healthcare announced that the Board of Directors of the Company at its meeting held on 14 November 2024, has recommended a First Interim dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.Powered by Capital Market - Live News

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Net profit of GPT Healthcare declined 0.20% to Rs 9.96 crore in the quarter ended June 2024 as against Rs 9.98 crore during the previous quarter ended June 2023. Sales rose 1.68% to Rs 97.82 crore in the quarter ended June 2024 as against Rs 96.20 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales97.8296.20 2 OPM %18.3619.83 - PBDT19.3418.50 5 PBT14.6614.16 4 NP9.969.98 0 Powered by Capital Market - Live News

GPT Healthcare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live News